Commonwealth Equity Services’s Capricor Therapeutics CAPR Stock Holding History

Commonwealth Equity Services’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$645K	Buy	26,775 +23	+0.1%	+$697	﹤0.01%	3112
2026 Q1	$813K	Buy	26,752 +464	+2%	+$12.4K	﹤0.01%	2785
2025 Q4	$759K	Sell	26,288 -4,572	-15%	-$59.7K	﹤0.01%	2817
2025 Q3	$223K	Sell	30,860 -2	-0%	-$15	﹤0.01%	3871
2025 Q2	$306K	Sell	30,862 -6	-0%	-$63	﹤0.01%	3558
2025 Q1	$293K	Buy	30,868 +210	+0.7%	+$2.92K	﹤0.01%	3523
2024 Q4	$423K	Sell	30,658 -622	-2%	-$10.9K	﹤0.01%	3103
2024 Q3	$476K	Buy	31,280 +1,280	+4%	+$6.33K	﹤0.01%	2930
2024 Q2	$143K	Sell	30,000 -990	-3%	-$5.52K	﹤0.01%	3734
2024 Q1	$210K	Hold	30,990	–	–	﹤0.01%	3577
2023 Q4	$152K	Hold	30,990	–	–	﹤0.01%	3596
2023 Q3	$106K	Buy	30,990 +990	+3%	+$5.56K	﹤0.01%	3559
2023 Q2	$143K	Hold	30,000	–	–	﹤0.01%	3502
2023 Q1	$126K	Buy	+30,000	New	+$129K	﹤0.01%	3446

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Commonwealth Equity Services's CAPR Position: Q2 2026 in Review

Commonwealth Equity Services increased its Capricor Therapeutics (CAPR) stake by 0.09% in Q2 2026, buying an estimated $697 and bringing the position to 26,775 shares worth $645K. The position accounts for ﹤0.01% of the portfolio, ranked #3112.

Commonwealth Equity Services first reported a position in CAPR in Q1 2023 and has held it in 14 quarters since. The position peaked at $813K in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

Commonwealth Equity Services held 26,775 shares of Capricor Therapeutics worth $645K as of Q2 2026.
Commonwealth Equity Services bought 23 Capricor Therapeutics shares in Q2 2026, an estimated $697.
Capricor Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3112 holding.
Commonwealth Equity Services first reported a position in Capricor Therapeutics in Q1 2023 and has held it in 14 quarters since.
Commonwealth Equity Services's Capricor Therapeutics position peaked at $813K in Q1 2026.
170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.